Gain Therapeutics Inc (GANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,504 | 303 | 0 | N/A | N/A |
| Receivables | 9 | 8 | 0 | N/A | N/A |
| Other current assets | 1,475 | 118 | 0 | 0 | 0 |
| TOTAL | $8,988 | $430 | $0 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 30 | 18 | 0 | N/A | N/A |
| Other Non-Current Assets | 587 | 212 | 0 | 0 | 0 |
| TOTAL | $617 | $231 | $N/A | $N/A | $N/A |
| Total Assets | $9,604 | $660 | $0 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 23 | N/A | 0 | N/A | N/A |
| Accounts payable and accrued liabilities | 962 | 154 | 0 | 0 | 0 |
| Other current liabilities | 769 | 250 | 0 | N/A | N/A |
| TOTAL | $2,115 | $879 | $0 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 716 | N/A | 0 | N/A | N/A |
| Deferred Revenues | 240 | 369 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 572 | 231 | 0 | 0 | 0 |
| TOTAL | $1,288 | $231 | $N/A | $N/A | $N/A |
| Total Liabilities | $3,402 | $1,110 | $0 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Retained earnings | -3,457 | -1,264 | 0 | N/A | N/A |
| Other shareholders' equity | -3,730 | -2,275 | 0 | 0 | 0 |
| TOTAL | $6,202 | $-450 | $0 | $N/A | $N/A |
| Total Liabilities And Equity | $9,604 | $660 | $0 | $0 | $0 |